Etiracetam
![]() | |
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-2-(2-Oxopyrrolidin-1-yl)butanamide | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status |
|
| Identifiers | |
| CAS Number | 33996-58-6 |
| ATC code | none |
| PubChem | CID 59708 |
| ChemSpider |
53863 |
| UNII |
230447L0GL |
| ChEMBL | CHEMBL1400561 |
| Chemical data | |
| Formula | C8H14N2O2 |
| Molar mass | 170.209 g/mol |
| Chirality | Racemic mixture |
| |
| |
| (verify) | |
Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active enantiomeric form is levetiracetam.
See also
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

